- Home
- CPS vs ITOS Comparison
CPS vs ITOS Comparison
Compare CPS & ITOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CPS
- ITOS
- Stock Information
- Founded
- CPS 1960
- ITOS 2011
- Country
- CPS United States
- ITOS United States
- Employees
- CPS N/A
- ITOS N/A
- Industry
- CPS Auto Parts:O.E.M.
- ITOS Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CPS Consumer Discretionary
- ITOS Health Care
- Exchange
- CPS Nasdaq
- ITOS Nasdaq
- Market Cap
- CPS 369.2M
- ITOS 381.2M
- IPO Year
- CPS N/A
- ITOS 2020
- Fundamental
- Price
- CPS $24.18
- ITOS $10.26
- Analyst Decision
- CPS Hold
- ITOS Hold
- Analyst Count
- CPS 1
- ITOS 6
- Target Price
- CPS $12.00
- ITOS $10.60
- AVG Volume (30 Days)
- CPS 189.6K
- ITOS 764.9K
- Earning Date
- CPS 07-31-2025
- ITOS 08-07-2025
- Dividend Yield
- CPS N/A
- ITOS N/A
- EPS Growth
- CPS N/A
- ITOS N/A
- EPS
- CPS N/A
- ITOS N/A
- Revenue
- CPS $2,721,537,000.00
- ITOS $35,000,000.00
- Revenue This Year
- CPS N/A
- ITOS N/A
- Revenue Next Year
- CPS $5.00
- ITOS N/A
- P/E Ratio
- CPS N/A
- ITOS N/A
- Revenue Growth
- CPS N/A
- ITOS 177.89
- 52 Week Low
- CPS $10.38
- ITOS $4.80
- 52 Week High
- CPS $26.73
- ITOS $18.13
- Technical
- Relative Strength Index (RSI)
- CPS 59.12
- ITOS 66.97
- Support Level
- CPS $23.03
- ITOS $10.05
- Resistance Level
- CPS $24.48
- ITOS $10.21
- Average True Range (ATR)
- CPS 0.96
- ITOS 0.13
- MACD
- CPS 0.23
- ITOS -0.06
- Stochastic Oscillator
- CPS 79.11
- ITOS 81.48
About CPS Cooper-Standard Holdings Inc.
Cooper-Standard Holdings Inc is engaged in the manufacture of sealing and fluid handling systems (consisting of fuel and brake delivery systems and fluid transfer systems). Its products are designed for passenger vehicles and light trucks that are manufactured by automotive original equipment manufacturers (OEMs) and replacement markets. It has two reportable segments: Sealing Systems and Fluid Handling Systems. The group's geographic regions are North America, Europe, Asia Pacific, and South America.
About ITOS iTeos Therapeutics Inc.
ITeos Therapeutics Inc is a biopharmaceutical company. It designs novel product candidates with optimized pharmacologic properties to improve clinical outcomes by restoring the immune response against cancer. The company's product candidates include EOS-850 which is an Adenosine A2A receptor-specific antagonist, and EOS-448 which is an ADCC-enabled, anti-TIGIT immune checkpoint blocking antibody among other drug candidates.